Taking PMVK as an example, it is a target of miR-874, which hindered the mevalonate pathway by depleting geranylgeranyl pyrophosphate (GGPP), subsequently activating the P53 pathway and promoting breast cancer cell apoptosis [24]. This evidence concerns the gene TP53 and breast cancer.